Chronic nicotine pretreatment protects the blood-brain barrier against nicotine-induced seizures in the rat

Pharmacological Research

Volumn 40, Issue 3, 1999, Pages 263-269

  Üzüm, Gülay ^a   Dïler, A Sarper ^a   Zïylan, Y Ziya ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Blood brain barrier; Nicotine; Seizures

Indexed keywords

EVANS BLUE; NICOTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BLOOD PRESSURE; BLOOD VESSEL PERMEABILITY; BRAIN CORTEX; BRAIN EDEMA; BRAIN MICROCIRCULATION; BRAIN PROTECTION; CEREBELLUM; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; CONVULSION; CORPUS STRIATUM; HIPPOCAMPUS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MEAN ARTERIAL PRESSURE; MESENCEPHALON; NONHUMAN; PRIORITY JOURNAL; RAT; RELATIVE DENSITY; SEIZURE; SPECTROPHOTOMETRY; SUBCUTANEOUS DRUG ADMINISTRATION; THALAMUS; TONIC CLONIC SEIZURE;

EID: 0344199407     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1999.0514     Document Type: Article

References (26)

1. Court JA, Perry EK. Nicotine receptors. Pharmacol Pathophysiol 1994; 2(3): 216-33.
2. Wecker L, Jian Lu Z. CNS neurotransmitters and neuromodulators, acetylcholine. In: Function of nicotinic receptors in CNS. TW Stone ed. Boca Raton FL: CRC Press, 1995: 105-14.
3. Abood LG, Salles A, Maiti A. Structure-activity studies of carbamat and other esters: Agonists and antagonists to nicotine. Pharmacol Biochem Behav 1987; 30: 403-8.
4. Borlongan CV, Shytle RD, Ross SD, Shimizu T, Frreman TB, Cahill DW, Sanberg PR. (-) Nicotine protects against systemic kainic acid-induced exitotoxic effects. Exp Neurol 1995; 136: 261-5.
5. Marin P, Maus S, Desagher J. Gaownski A, Premont J. Nicotine: A new neuroprotective agent. Neuroreport 1994; 5: 1977-80.
6. Diler AS, Üzüm G, Lefauconnier JM, Ziylan YZ. Biology and physiology of the blood-brain barrier. In: Advances in behavioral biology. Couraud P-O, Scherman D, eds. New York: Plenum Press, 1996; 46: 333-8.
7. Üzüm G, Curgunlu S, Hacialioǧlu M, Ercan S, Diler AS, Ziylan YZ. Protective effect of chronic administration of nicotine on neuronal and vascular functions in the brain. Eur J Neurosci 1993; Suppl 6: 93S358.
8. Johonsson B, Li CH, Olsson Y, Klatzo J. The effect of acute arterial hypertension on the blood-brain barrier to protein tracers. Acta Neurol Pathol 1970; 16: 117-24.
9. Ziylan YZ, Astes N. Age-related changes in regional patterns of blood-brain barrier breakdown during epileptiform seizures induced by pentylenetetrazol. Neurosci Lett 1989; 96: 179-84.
10. De Fiebre C, Collins AC. Decreased sensitivity to nicotine induced seizures as a consequence of nicotine pretreatment with Long-Sleep and Short-Sleep Mice. Alcohol 1988; 5: 55-61.
11. Hulien-Gublin BA, Lumpkin MD, Kellar KJ. Effects of chronic administration of nicotine on prolactin release in the rat: Inactivation of prolactin response by repeated injections of nicotine. J Pharmacol Exp Ther 1990; 252: 21-5.
12. Rössner N, Tempel K. Quantitative Bestimmung der Permeabilität der sagenonnten blut-hirnschranke für Evans-Blau (T 1824): Med Pharmacol Exp 1966; 14: 169-82.
13. Nelson S, Manz M. Use of specific gravity in the measurement of cerebral edema. J Appl Physiol 1971; 30: 268-71.
14. Bolwing TG, Hertz MM, Holm JJ. Blood brain barrier permeability during electroshock seizures in the rat. Eur J Clin Invest 1977; 7: 95-100.
15. Lee JC, Olszewki J. Increased cerebrovascular permeability after repeated electroshock. Neurology 1961; 11: 515-19.
16. Nitsch C, Klatzo I. Regional patterns of blood-brain barrier breakdown during epilepti form seizures induced by various convulsive agents. J Neurol Sci 1983; 59: 305-22.
17. Ziylan YZ. Pathophysiology of the opening of the blood-brain barrier and blood-cerebro spinal fluid barriers in acute hypertension. Exp Neurol 1984: 18-28.
18. Nitsch C, Goping G, Klatso I. Pathophysiological aspects of blood-brain barrier permeability in epileptic seizures. In: Advances in experimental medicine and biology, vol 203. Exitatory amino acids and epilepsia. Schwarz R, Ben-Ari Y, eds. New York, London 1986: 175-84.
19. Wecker L, Yu ZJ. Function of nicotinic receptor in the CNS. In: CNS Neurotransmitter and neuromodulators. Boca Raton, FL: Acetylcholine CRC Press, 1995: 105-14.
20. Summers KL, Glacabini E. Effects of local and repeated systemic administration of (-) nicotine on extracellular levels of acetylcholine, norepinephrine, dopamine, and serotonin in rat cortex. Neurochem Res 1995; 20: 753-9.
21. Pomerleau OF, Rosecrans JI. Neuroregulatory effects of nicotine. Psychoneuroendocrinology 1989; 92: 135-43.
22. Owman C, Fuxe K, Janson AM, Kahström J. Studies of protective actions of nicotine on neuronal and vascular functions in the brain of rats; comparison between sympathetic noradrenaergic and mesostriatal dopaminergic fiber systems and the effect of a dopamine agonist. In: Progress in brain research. Nordberg A, Fuxe K, Holmsted B, Sudwall A, eds. Vol 79, Chap 26. Elsevier Science Publishers BV 1989: 267-76.
23. Ziylan YZ, Lefauconnier JM, Bernard G, Bourre JM. Regional alterations in blood to brain transfer of α-aminoisobutyric acid and sucrose after chronic administration and withdrawal of dexamethasone. J Neurochem 1989; 52: 684-90.
24. Ziylan YZ, Lefauronnier JM, Bernard G, Bourre JM. Hormonal influence on the permeability of the blood-brain barrier: effect of an analog of adrenocorticotropic hormone, β1-24 corticotrophin. Neurosci Lett 1993; 151: 59-63.
25. Simasko SM, Soares JR, Weiland GA. Two components of carbomylcholine-induced loss of nicotinic acetylcholine receptor function in the neuronal cell line PC 12. Mol Pharmacol 1986; 30: 6-12.
26. Barrass BC, Blackburn JW, Brimblerombe RW, Rich P. Modifications of nicotine toxicity by treatment with different drugs. Biochem Pharmacol 1969; 18: 2145-52.